D69.3
Immune thrombocytopenic purpura
Clinical Classification Guidelines
Inclusion Terms
- Hemorrhagic (thrombocytopenic) purpura
- Idiopathic thrombocytopenic purpura
- Tidal platelet dysgenesis
Medical Intelligence & Overview
Immune Thrombocytopenic Purpura (ITP) is a condition where the immune system mistakenly attacks and destroys platelets, which are small blood cells vital for clotting. This reduction in platelets can lead to easy bruising, bleeding, and the appearance of purple or red spots on the skin called purpura. ITP can affect individuals of any age but is most common in children and young adults. While it can sometimes resolve on its own, in other cases, medical treatment is necessary to prevent severe bleeding and manage symptoms.
Causes & Symptoms
Clinical Causes: The exact cause of immune thrombocytopenic purpura is often unknown, which is why it is termed 'idiopathic'. The immune system produces antibodies that mistakenly target and destroy platelets. ITP can develop after infections, such as viral infections like hepatitis C or HIV. Certain medications may trigger immune responses leading to platelet destruction. In some cases, ITP is associated with other autoimmune disorders, like lupus or rheumatoid arthritis. Less commonly, it may result from other blood disorders or be a side effect of medical conditions.
Key Symptoms: Easy or excessive bruising on the skin and tissues. Large, flat purple or red spots (purpura) appearing on the skin. Superficial bleeding, such as bleeding from the gums or nose. Tiny red spots (petechiae), especially on the lower legs. In severe cases, internal bleeding or bleeding in organs may occur, leading to more serious complications. In children, symptoms often develop suddenly and may occur after an infection. In adults, symptoms tend to be more persistent and may lead to prolonged bleeding episodes.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of medical history review, physical examination, and specific blood tests. Blood tests measure platelet counts and assess for signs of other blood disorders or autoimmune diseases. Additional tests, such as bone marrow examination, may be conducted in uncertain cases or if the diagnosis is suspected to involve other conditions. The primary goal is to exclude other causes of low platelets, such as leukemia or medication effects.
Treatment Protocols: Treatment strategies depend on the severity of the condition and symptom presentation. Options may include: - Medications that boost platelet production or suppress the immune response, such as corticosteroids. - Intravenous immunoglobulin (IVIG) to quickly raise platelet counts. - Immunosuppressive drugs in cases resistant to initial treatments. - In severe or refractory cases, procedures like splenectomy (removal of the spleen) might be considered. - Close monitoring of platelet levels and bleeding episodes is essential. - Lifestyle modifications to minimize injury risk and bleeding complications. While some children with ITP recover spontaneously, ongoing management and consultation with healthcare providers are vital for all patients to ensure effective control and to reduce the risk of severe bleeding.
Clinical Advice & FAQs
Billing Guidance
Is D69.3 a billable ICD-10 code?
Yes, D69.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D69.3?
Clinical documentation must specify the nature of Immune thrombocytopenic purpura and any associated comorbidities for accurate reporting.
Cite this Clinical Reference